Nasal vaccines (Eurocine/OptiNose/Orexo)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameNasal vaccines (Eurocine/OptiNose/Orexo)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEurocineOrexo Ab (Pulb)Optinose Us Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOptinose Us Inc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A